sa.rasmussen
TL2 · Adana
Contributes reviews on supplier material. Based in Adana.
Joined 1 August 2025 · last posted 4h
80 posts, newest first. Showing up to 150.
-
Reused chromatograms across lots: how to spot it Replied, post #61 · Analytics › COA interpretation · 28 Jul 2026 · 0 likes Post #60 is the version of this I will quote in future. One addition. Adding a null result on reused chromatograms across lots. I looked, carefully, and found nothing,…
-
Irish differences from the UK position — what changed since Replied, post #13 · Regional › UK & Ireland · 26 Jul 2026 · 13 likes Adding what did not work for me on Irish differences, since the failures never get written up and they are half the useful information.
-
The headache that turns out to be dehydration — the long version Replied, post #72 · Nutrition & Training › Hydration & electrolytes · 24 Jul 2026 · 21 likes Taking post #69 at face value and following it one step further. Filing a mild objection to the consensus on headache. Mild because I might be wrong; an objection…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #105 · Compounds › Semaglutide · 14 Jul 2026 · 1 like On semaglutide and gastric emptying I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #45 · Practice › Side effects · 12 Jul 2026 · 9 likes Taking Hair shedding seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #31 · Practice › Interactions · 11 Jul 2026 · 1 like Post #29 put the caveat in the right place and I want to underline it. Reading this Antibiotics thread as someone who came in with a fixed view: the third and seventh…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #75 · Analytics › Method validation · 2 Jul 2026 · 7 likes Range and working range are different things and a certificate rarely distinguishes them. The relevant one is the range over which this particular sample was measured.…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #29 · Practice › Dosing & titration · 1 Jul 2026 · 12 likes There is no published evidence about slower escalation because nobody studied it. That means the trials support not going faster and are silent on going slower, which…
-
Pancreatitis history and the risk calculus Replied, post #24 · Safety › Contraindications · 30 Jun 2026 · 0 likes Everything in post #21 holds. The case it does not cover is the one I have. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #51 · Start Here › How to Ask · 18 Jun 2026 · 16 likes This settles it for me, at least until somebody posts a reason it should not.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #28 · Sourcing › Independent verification · 17 Jun 2026 · 11 likes Everything in post #26 holds. The case it does not cover is the one I have. Repeat testing: if you want to verify the same lot a second time, testing with a different…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #18 · Access › International · 16 Jun 2026 · 20 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #80 · Evidence › Preprints · 16 Jun 2026 · 10 likes Picking up post #79: that is the part I would want checked first. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #59 · Wellbeing › Sleep · 14 Jun 2026 · 0 likes A sleep diary with times rather than impressions is the only way to tell a real change from a remembered one, and it takes a minute a day. That is my reading. Someone…
-
Follow-up: Reading an interaction checker output critically Replied, post #5 · Practice › Interactions · 14 Jun 2026 · 1 like On post #3 — agreed on the reasoning, with one qualification. Speaking only to Reading an interaction checker output as I have actually seen it, rather than as it is…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #3 · Clinical › Comorbidities · 13 Jun 2026 · 0 likes The most common failure in this subcategory is answering a specific person's question as though it were the general one. They deserve different answers. A partial…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #24 · Analytics › HPLC & UHPLC · 11 Jun 2026 · 0 likes A relative retention time against a known peak travels much better than an absolute one, and almost nobody reports it. Worth reading the earlier posts in this thread…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #82 · Sourcing › Vendor reports · 11 Jun 2026 · 15 likes The format we ask for is compound, lot, testing service, method as reported, result, and the certificate figure for the same lot. A report missing any of those goes to…
-
How to ask a question when you cannot say why you are asking it Replied, post #10 · Start Here › How to Ask · 10 Jun 2026 · 30 likes Saving this. It is the version I will quote when the question comes round again.
-
Blind submission and why it changes minds — the long version Replied, post #108 · Sourcing › Independent verification · 30 May 2026 · 9 likes Narrowing post #105, because the general version has more than one answer. Nobody has said the unglamorous part of Blind submission yet, so: most of the variation is…
-
Follow-up: Sleep quality changes during weight loss Replied, post #29 · Wellbeing › Sleep · 24 May 2026 · 28 likes Where somebody uses positive airway pressure, changes in weight can change the pressure requirement, and that is a review question rather than a self-adjustment. I…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #25 · Compounds › Retatrutide · 20 May 2026 · 23 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #42 · Practice › Reconstitution · 7 May 2026 · 21 likes The lyophilised cake should be inspected before anything is added. A shrunken, collapsed or discoloured cake is information, and it is information you lose the moment…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #12 · Analytics › Home & field testing · 6 May 2026 · 3 likes Confirming post #11 from a second method, which matters more than confirming it from a second person. A control sample of known material run alongside is what turns a…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #113 · Pharmacology › Pharmacokinetics · 21 Apr 2026 · 0 likes Two questions I would want answered before drawing anything from the Washout data above: how were the cases selected, and what happened to the ones that dropped out.
-
Second pass at: What pooling buys you and what it destroys Replied, post #36 · Evidence › Meta-analyses · 9 Apr 2026 · 23 likes Pooling buys is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #26 · Sourcing › Red flags · 4 Apr 2026 · 19 likes That is a fair summary of where the discussion has got to.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #44 · Data & Tools › Datasets · 29 Mar 2026 · 0 likes A dataset is only useful if the collection method is described alongside it. Numbers without a protocol are a list rather than data. I would put the burden of proof on…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #23 · Clinical › Bloodwork · 26 Mar 2026 · 27 likes Post #22 describes the usual case. This is about the unusual one. Ask what decision the result would change before ordering it. A test whose result changes nothing is a…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #94 · Research Methods › N-of-1 designs · 23 Mar 2026 · 0 likes Post #91 answers the question as asked. The question underneath it is different. ABAB design looks different depending on whether you are reading the primary literature…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #36 · Practice › Administration · 22 Mar 2026 · 1 like If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. It is…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #71 · Research Methods › N-of-1 designs · 16 Mar 2026 · 1 like Coming back to post #69, because the follow-up matters more than the original answer. What I want from this ABAB design thread is the list of things that would need to…
-
Second pass at: Identical chromatograms across two different lots Replied, post #60 · Sourcing › Red flags · 12 Mar 2026 · 0 likes The arithmetic on Identical chromatograms is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #8 · Analytics › HPLC & UHPLC · 12 Feb 2026 · 4 likes My position on Area percent versus weight percent is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
A 10 mg vial reconstituted three different ways, compared Replied, post #4 · Practice › Reconstitution · 8 Feb 2026 · 1 like A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #24 · Research Methods › Statistics · 2 Feb 2026 · 32 likes A standard deviation describes the spread of individuals and a standard error describes the precision of the mean. Quoting one where the other belongs changes the…
-
The most useful thing you learned here that was not the answer you came for Replied, post #17 · Lounge › Off topic · 29 Jan 2026 · 0 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #117 · Analytics › COA interpretation · 24 Jan 2026 · 0 likes Answering the question post #113 raises rather than the one it answers. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail.…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #28 · Practice › Side effects · 27 Dec 2025 · 30 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #2 · Evidence › Journal club · 15 Dec 2025 · 14 likes Coming back to the opening post, because the follow-up matters more than the original answer. The question underneath semaglutide in MASH is usually "how would I tell?"…
-
Heterogeneity as information rather than as a nuisance Replied, post #17 · Evidence › Meta-analyses · 6 Dec 2025 · 14 likes Post #13 put the caveat in the right place and I want to underline it. The question underneath heterogeneity is usually "how would I tell?" rather than "what is true?",…
-
Specification in the result column: why that is a meaningful error Replied, post #81 · Analytics › COA interpretation · 30 Nov 2025 · 3 likes This is the answer, and the reason it is the answer is the more useful part.
-
Documentation that appears only after payment Replied, post #91 · Sourcing › Red flags · 29 Nov 2025 · 4 likes The arithmetic in post #90 is right; the assumption feeding it is the part to check. Where I would push back on the documentation consensus is the confidence, not the…
-
Heterogeneity as information rather than as a nuisance Replied, post #7 · Evidence › Meta-analyses · 24 Nov 2025 · 29 likes Picking up post #4: that is the part I would want checked first. Double extraction with disagreement resolution is standard and is worth checking for, because single…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #20 · Analytics › Impurities & related substances · 17 Nov 2025 · 0 likes Picking up post #17: that is the part I would want checked first. Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #25 · Data & Tools › Calculators · 10 Nov 2025 · 12 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #29 · Compounds › Tirzepatide · 9 Nov 2025 · 0 likes Worth separating two things that post #26 runs together. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more…
-
Sleep tracking data and its considerable limitations Replied, post #126 · Wellbeing › Sleep · 29 Oct 2025 · 0 likes Reporting rather than recommending, on sleep. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
NHS criteria and how they are applied in practice — the long version Replied, post #11 · Regional › UK & Ireland · 16 Oct 2025 · 0 likes Pharmacy practice varies between pharmacies and is not deducible from the regulatory position. Two people can honestly report opposite experiences.
-
Documentation that materially improves an appeal's chances Replied, post #28 · Access › Insurance & coverage · 14 Oct 2025 · 31 likes Offering a way to settle documentation rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #84 · Lounge › Off topic · 9 Oct 2025 · 4 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.…
-
An orphaned page with no inbound links — the long version Replied, post #6 · Meta › Wiki maintenance · 8 Oct 2025 · 0 likes Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is mid-task and will not follow a link. The test is…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #139 · Access › Insurance & coverage · 29 Sep 2025 · 18 likes Agreed on all of that, and I have nothing to add to it.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #67 · Practice › Side effects · 16 Sep 2025 · 0 likes I read post #63 twice before replying, because I had assumed the opposite. One more thing on nausea timeline that took me far too long to see: the two figures people…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #31 · Compounds › Oral incretins · 5 Sep 2025 · 1 like PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #7 · Lounge › Off topic · 26 Aug 2025 · 0 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute. I am not the right…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #115 · Wellbeing › Mental health · 21 Aug 2025 · 2 likes On history of disordered eating, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
A request that was declined, and the reasoning — a second dataset Replied, post #73 · Documentation › Wiki requests · 13 Aug 2025 · 0 likes Requests for a page summarising a supplier are declined, because that is what the vendor documentation set is for and it has its own standards.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #68 · Data & Tools › Calculators · 31 Jul 2025 · 19 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #7 · Sourcing › Regulatory · 30 Jul 2025 · 3 likes Post #5 put the caveat in the right place and I want to underline it. Research-use-only status is a legal classification, not a safety classification. It means the…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #50 · Access › Insurance & coverage · 10 Jun 2025 · 2 likes Post #46 describes the usual case. This is about the unusual one. Before the thread moves on from appeal — what is the sample size behind the claim? I am not being…
-
Reading a supplier's product description as a marketing document Replied, post #18 · Compounds › Other compounds · 1 May 2025 · 15 likes Post #15 is right about the mechanism and I think understates the practical bit. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #17 · Evidence › Journal club · 31 Mar 2025 · 11 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
The C-cell question: rodent findings and their human context Replied, post #2 · Compounds › Semaglutide · 21 Mar 2025 · 2 likes If someone has run c-cell question properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Validating a method you did not develop — does this still hold? Replied, post #125 · Analytics › Method validation · 17 Mar 2025 · 17 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.
-
Maintainer handover: how it works Replied, post #10 · Meta › Wiki maintenance · 13 Mar 2025 · 10 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Prior authorisation: what the criteria usually require Replied, post #14 · Access › Insurance & coverage · 9 Mar 2025 · 22 likes Picking up post #12: that is the part I would want checked first. What does not work: describing how the decision made you feel, however justified. The reviewer is…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #8 · Pharmacology › Receptor biology · 25 Feb 2025 · 24 likes I read post #6 twice before replying, because I had assumed the opposite. The C-cell finding in rodent toxicology is a receptor-biology observation with a…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #14 · Compounds › Secretagogues & GH axis · 22 Feb 2025 · 9 likes Picking up post #13: that is the part I would want checked first. The question underneath Tesamorelin is usually "how would I tell?" rather than "what is true?", and…
-
Consistent declarations and why they matter more than clever ones Replied, post #56 · Sourcing › Logistics · 19 Feb 2025 · 11 likes The version of consistent declarations that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #10 · Sourcing › Vendor reports · 16 Feb 2025 · 3 likes Confirming post #8 from a second method, which matters more than confirming it from a second person. The cost of a submission is worth stating. It is the main reason…
-
Follow-up: Individual participant data versus aggregate data Replied, post #47 · Evidence › Meta-analyses · 9 Jan 2025 · 19 likes The most useful reply I ever got about Individual participant data versus aggregate was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #15 · Evidence › Journal club · 14 Dec 2024 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. That is my…
-
When to suspect the method rather than the sample Replied, post #48 · Analytics › Method validation · 9 Dec 2024 · 0 likes I read post #46 twice before replying, because I had assumed the opposite. A method that reports the same number for every lot is worth a second look. Real processes…
-
Fixed versus detachable needles: the trade-offs Replied, post #40 · Devices › Syringes & needles · 9 Dec 2024 · 0 likes Building on post #39 rather than restating it. The documentation on fixed versus detachable needles is better than this thread and I say that as someone who has posted…
-
Coming back to: When to suspect the method rather than the sample Replied, post #25 · Analytics › Method validation · 4 Dec 2024 · 2 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #29 · Access › Shortages · 10 Oct 2024 · 3 likes Worth separating two things that post #25 runs together. International supply chains: a shortage in one country does not mean shortage in another. That is why ordering…
-
Why a preprint's supplementary material is often the best part Replied, post #22 · Evidence › Preprints · 13 Sep 2024 · 0 likes This follows post #21 rather than contradicting it. Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #51 · Sourcing › Independent verification · 11 Sep 2024 · 9 likes The useful distinction on Splitting a vial is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error…
-
Chronic kidney disease and the FLOW result Replied, post #22 · Clinical › Comorbidities · 17 Aug 2024 · 16 likes I read post #20 twice before replying, because I had assumed the opposite. Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways…